Genetic Testing
care offers a variety of genetic tests as part of our integrative biomedical approach to healthcare. Advances in genetic testing have allowed nutritional and medical interventions to be individualized in ways not previously possible. Autism, attention deficit disorder, multiple sclerosis, Down syndrome, Alzheimer’s, and depression are among the conditions that can be associated with neurological inflammation and certain genes appear to predispose to this inflammation. Knowledge of genetic weaknesses allows nutritional interventions to be optimized and alerts individuals at high risk for certain conditions to the need for closer medical supervision.
Pre-Pregnancy Genetic Testing
Family history may indicate that genetic testing prior to pregnancy would be
of benefit. Individuals with a family history of autism, attention deficit
disorder, bipolar disorder, autoimmune disease, birth defects, Alzheimer's,
or heart disease may choose to assess their own risk factors for these
diseases. Treatment of high-risk conditions with improvements in lifestyle
and nutritional status prior to conception will optimize one's chance of a
healthy pregnancy. If genes known to increase the risk of certain medical
conditions are present, this risk can often be mitigated through the
avoidance of environmental triggers of disease and the provision of
nutrients proven to decrease the incidence and/or severity of these
conditions.
Genetic Testing for Neurological Disease
Defects in the ability to utilize vitamins such as folic acid and B12, the
ability to clear toxins from the body, and the ability to repair free
radical damage to cells may increase the risk of developing neurological
disorders such as autism, attention deficit disorder, depression, bipolar
disorder, Alzheimer's, Parkinson's disease, Tourette's syndrome, and other
neurological conditions. Individuals with symptoms of disease or a family
history of neurological disorders may elect testing to identify risk factors
amenable to treatment.
Genetic Testing for Cardiovascular Risk
In addition to lifestyle, the interaction of several genes is known to
contribute to each person's risk of developing heart disease and compromised
blood flow throughout the body. The genes for methylenetetrahydrofolate
reductase (MTHFR), for example, determine one's ability to utilize folic
acid. If genetic weaknesses are identified, disease risk is likely to be
reduced with the use of medical grade nutritional supplements. Other genes
of interest include those relating to cholesterol production and metabolism,
blood pressure, and blood clotting.
Alzheimer's Disease
Genetic testing for the APO E gene can assist in determining an individual's
risk of developing Alzheimer's. Additional testing may be indicated to
assess detoxification pathways and glutathione levels. Exposure to
aluminum, lead, mercury, and other metals
Top of Page